Advertisement
Advertisement
U.S. markets open in 7 hours 11 minutes
Advertisement
Advertisement
Advertisement
Advertisement

OceanTech Acquisitions I Corp. (OTECU)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
10.53+0.30 (+2.93%)
At close: 12:27PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close10.23
Open10.53
Bid0.00 x 1100
Ask0.00 x 900
Day's Range10.53 - 10.53
52 Week Range10.05 - 10.53
Volume1,328
Avg. Volume1,644
Market CapN/A
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for OTECU

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Business Wire

      OceanTech Acquisitions I Corp. and Captura Biopharma, Inc. Announce Signing of Definitive Business Combination Agreement

      NEW YORK, August 10, 2022--Captura Biopharma, an emerging biotechnology company developing and commercializing oral chelators to treat internal transuranic radionuclide contamination and heavy metal poisoning, and OceanTech Acquisitions I Corp. ("OceanTech") (Nasdaq: OTEC/OTECU and OTECW), a special purpose acquisition company, today announced that they have entered into a definitive business combination agreement (the "Merger Agreement") that will result in Captura Biopharma becoming a publicly

    • Business Wire

      OceanTech Acquisitions I Corp. Confirms Funding to Extend Period to Consummate Initial Business Combination

      NEW YORK, June 02, 2022--OceanTech Acquisitions I Corp. ("OceanTech" or the "Company") (Nasdaq: OTECU), a special purpose acquisition company, today announced that it has caused to be deposited $1,548,900 into the Company’s Trust account for its public stockholders, representing $0.15 per public share, allowing the Company to extend the period of time it has to consummate its initial business combination by six months from June 2, 2022 to December 2, 2022 (the "Extension"). The Extension is perm

    • Business Wire

      OceanTech Acquisitions I Corp. Confirms Intention to Extend Period to Consummate Initial Business Combination

      NEW YORK, May 23, 2022--OceanTech Acquisitions I Corp. ("OceanTech" or the "Company") (Nasdaq: OTECU), a special purpose acquisition company, today announced that it will extend the period of time it has to consummate its initial business combination by six months from June 2, 2022 to December 2, 2022 (the "Extension"). OceanTech Acquisitions I Sponsors LLC (the "Sponsor"), has notified the Company that it intends to purchase 1,548,900 private placement warrants at $1.00 per warrant by depositin

    Advertisement
    Advertisement